GRIFOLS S A/S (NASDAQ:GRFS) Stock Rating Upgraded by ValuEngine

Share on StockTwits

ValuEngine upgraded shares of GRIFOLS S A/S (NASDAQ:GRFS) from a sell rating to a hold rating in a research note released on Saturday, ValuEngine reports.

Other research analysts also recently issued research reports about the company. Barclays reiterated an overweight rating on shares of GRIFOLS S A/S in a research note on Monday, June 1st. Morgan Stanley restated an overweight rating on shares of GRIFOLS S A/S in a research note on Tuesday, June 23rd. Berenberg Bank restated a buy rating on shares of GRIFOLS S A/S in a research note on Wednesday, June 10th. BidaskClub downgraded GRIFOLS S A/S from a buy rating to a hold rating in a research note on Thursday, May 28th. Finally, Zacks Investment Research upgraded GRIFOLS S A/S from a strong sell rating to a hold rating in a research note on Wednesday, June 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $24.00.

GRFS stock opened at $18.24 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.90 and a current ratio of 2.75. The company has a market capitalization of $12.88 billion, a price-to-earnings ratio of 16.29, a PEG ratio of 0.99 and a beta of 0.83. GRIFOLS S A/S has a fifty-two week low of $13.40 and a fifty-two week high of $25.73. The stock has a fifty day moving average of $19.57 and a 200-day moving average of $21.38.

GRIFOLS S A/S (NASDAQ:GRFS) last posted its quarterly earnings results on Tuesday, April 21st. The biotechnology company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.01. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.40 billion. GRIFOLS S A/S had a return on equity of 11.92% and a net margin of 13.31%. Equities analysts predict that GRIFOLS S A/S will post 1.36 EPS for the current year.

Large investors have recently added to or reduced their stakes in the business. Sowell Financial Services LLC purchased a new stake in shares of GRIFOLS S A/S in the 1st quarter valued at about $29,000. Harbor Investment Advisory LLC raised its holdings in shares of GRIFOLS S A/S by 149,100.0% in the 1st quarter. Harbor Investment Advisory LLC now owns 1,492 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 1,491 shares in the last quarter. RMR Wealth Builders purchased a new stake in shares of GRIFOLS S A/S in the 4th quarter valued at about $45,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its holdings in shares of GRIFOLS S A/S by 21.3% in the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 9,428 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 1,653 shares in the last quarter. Finally, Advisors Asset Management Inc. raised its holdings in shares of GRIFOLS S A/S by 11.6% in the 4th quarter. Advisors Asset Management Inc. now owns 8,487 shares of the biotechnology company’s stock valued at $198,000 after acquiring an additional 882 shares in the last quarter. 17.88% of the stock is currently owned by hedge funds and other institutional investors.

GRIFOLS S A/S Company Profile

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products.

Featured Story: What does relative strength index mean?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for GRIFOLS S A/S (NASDAQ:GRFS)

Receive News & Ratings for GRIFOLS S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRIFOLS S A/S and related companies with MarketBeat.com's FREE daily email newsletter.